Varela RW, Cabrera OA

Language: Spanish
References: 22
Page: 79-83
PDF size: 218.10 Kb.

ABSTRACT

Leptospirosis is a zoonotic spirochetal disease of global importance. This disease continues to have a major impact on people living in urban and rural areas of developing countries with inestimable morbidity and mortality. We report a fatal case of lung involvement leptospirosis, characterizing a picture of diffuse alveolar damage. There are many forms of clinical presentations for this disease and often signs and symptoms may be nonspecific. Leptospirosis diagnosis is based on suspicion and compatible epidemiologic clinical context and confirmed by serologic tests.
Alveolar hemorrhage presented as dyspnea and hemoptysis is the main pulmonary mani-festation. The emergence of massive hemoptysis and acute respiratory distress syndrome has characterized the recent changes reported in the clinical patterns of leptospirosis. The pulmonary involvement has been emerged as a serious life threat, becoming the main cause of death due to leptospirosis in some countries.

REFERENCES

1. Abuauad MC, Osorios G, Rojas JL, Pino L. Leptospirosis: Presentación de una infección fulminante y revisión de la literatura. Rev Chil Infect 2005; 22 (1): 93-97.

2. Dolhnikoff M, Mauad T, Bethlem EP, Ribeiro CR. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Bra J Infect Dis 2007; 11 (1): 142-148.

3. Dupont H., Dupont-Perdrizet D., Perie J.L., et al. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 1997; 25:720-4.

4. Gouveia EL, Metcalfe J, de Carvalho AL, Aires TS, et al. Leptospirosis associated severe pulmonary hemorrhage syndrome, Salvador, Brazil. Emerg Infect Dis 2008; 14(3): 505-508.

5. Ittyachen AM, Krishnapillai TV, Nair MC, Rajan AR. Retrospective study of severe of leptospirosis admitted in the intensive care unit. J Postgrad Med 2007; 53: 232-235.

6. Jauréguiberry S, Roussel M, Brinchault-Rabin G, Gacouin A, Le Meur, A, Arvieux C, et al. Clinical presentation of leptospirosis: a restrospective study of 34 patients admitted to single institution in France. Clin Microbiol Infect 2005; 11: 391-394.

7. Jones S, Kim T. Fulminant leptospirosis in patient with human immunodeficiency virus infection: Case report and review of the literature. Clin Infect Dis 2001; 33: e31-3.

8. Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14(2): 296-326.

9. Lucks AM, Lakshminarayanan S, Hirschmann JV. Leptospirosis as diffuse alveolar hemorrhage: Case report and literature review. Chest 2003; 123: 639-643.

10. Marotto P.C., Nascimento C.M., Eluf-Neto J., et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999; 29:1561-3.

11. Orpilla-Bautista IC, Panaligan MM. Predictors of mortality among patients with leptospirosis admitted at the JRRMMC. Phil J Microbiol Infect Dis 2001; 31(4): 145-149.

12. Panaphut T, Domrongkitchaiporn S, Vibhgool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis 2003; 36:1507-13.

13. Phimda K, Hoontrakul S, Suttinont C, Charconwat S, Losuwanaluk K, et al. Doxicicline versus azithromycin treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother 2007; 51(9): 3259-3263.

14. Quintanilla J, Richmond J, Gourzong C. Leptospirosis y sindrome de Weil. Revista Médica de Costa Rica y Centroamérica 2004; LXI(366):3-9.

15. Sambasiva RR, Naveen G, Bhalla P, Agarwal SK. Leptospirosis in India and the rest of world. Bra J Infect Dis 2003; 7(3): 178-193.

16. Segura ER, Ganoza CA, Campos K, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a región of endemicity, with quantification of leptospira burden. Clin Infect Dis 2005; 40: 343-351.

17. Speelman P. Leptospirosis. En: Kasper LD, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL: Harrison: Principios de Medicina Interna, 16 ed, México, Mc Graw Hill, 1100-1103.

18. Spichler A, Moock M, Chapola E, Vinetz J. Weil´s disease; An unusually fulminant presentation characterized by pulmonary hemorrhage and shock. Bra J Infect Dis 2005; 9(3): 336-340.

19. Subash GS, Harling D. Acute lung injury and multi-organ dysfunction; an unusual manifestation of leptospirosis. Br J Anaesth 2007; 98: 549–50.

20. Teglia OF, Battagliotti C, Villavicencio RL, et al. Leptospiral pneumonia. Chest 1995; 108:874–5.

21. Thammakumpee K, Silpapojakul K, Borrirak B. Leptospirosis and its pulmonary complications. Respirology 2005; 10: 656-659.

22. Trevejo R, Rigau J. Epidemic Leptospirosis Associated with Pulmonary Hemorrhage Nicaragua 1995. The Journal of Infectious Disease 1998; 178:1457-1463.